blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2872172

EP2872172 - MYCOBACTERIAL ANTIGEN VACCINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.09.2019
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  12.10.2018
FormerGrant of patent is intended
Status updated on  05.07.2018
FormerExamination is in progress
Status updated on  17.02.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Transgene SA
Parc d'Innovation Boulevard Gonthier d`Andernach
67400 Illkirch Graffenstaden / FR
[2015/21]
Inventor(s)01 / TUPIN, Emmanuel
Fredsborgsgatan 1
117 59 Stockholm / SE
02 / MICOL, Romain
11 quai Général Sarrail
69006 Lyon / FR
03 / COUPET, Charles Antoine
38 avenue de limburg
69110 Sainte Foy Les Lyon / FR
04 / INCHAUPSE, Geneviève
4 rue Villon
Les Jardins de l'Europe
69003 Lyon / FR
05 / GOUANVIC, Marie
16 rue Lavoisier
69003 Lyon / FR
06 / SILVESTRE, Nathalie
6, rue des Iris
67120 Ergersheim / FR
07 / MARCHAND, Jean-Baptiste
1A rue des Hauts Pâturages
67210 Obernai / FR
08 / BENY, Cécile
14 Chemin des Chênes
Le Marchais Rallu
89320 Cerisiers / FR
 [2015/21]
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2015/21]
Application number, filing date13735275.310.07.2013
[2018/46]
WO2013EP64624
Priority number, dateEP2012030582510.07.2012         Original published format: EP 12305825
EP2012030653907.12.2012         Original published format: EP 12306539
EP2013030573703.06.2013         Original published format: EP 13305737
[2015/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2014009438
Date:16.01.2014
Language:EN
[2014/03]
Type: A2 Application without search report 
No.:EP2872172
Date:20.05.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 16.01.2014 takes the place of the publication of the European patent application.
[2015/21]
Type: B1 Patent specification 
No.:EP2872172
Date:14.11.2018
Language:EN
[2018/46]
Search report(s)International search report - published on:EP10.04.2014
ClassificationIPC:A61K39/04
[2015/21]
CPC:
A61K39/04 (EP,US); A61P31/06 (EP); C07K14/35 (US);
C07K16/1289 (EP,US); A61K2039/51 (US); A61K2039/53 (EP,US);
C07K2319/00 (EP,US); C07K2319/40 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/21]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:IMPFSTOFF MIT EINEM MYKOBAKTERIELLEN ANTIGEN[2015/21]
English:MYCOBACTERIAL ANTIGEN VACCINE[2015/21]
French:VACCIN ANTIGÉNIQUE MYCOBACTÉRIEN[2015/21]
Entry into regional phase10.02.2015National basic fee paid 
10.02.2015Designation fee(s) paid 
10.02.2015Examination fee paid 
Examination procedure10.02.2015Examination requested  [2015/21]
14.09.2015Amendment by applicant (claims and/or description)
21.02.2017Despatch of a communication from the examining division (Time limit: M06)
03.08.2017Reply to a communication from the examining division
07.06.2018Date of oral proceedings
03.07.2018Minutes of oral proceedings despatched
06.07.2018Communication of intention to grant the patent
28.09.2018Fee for grant paid
28.09.2018Fee for publishing/printing paid
28.09.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.02.2017
Opposition(s)15.08.2019No opposition filed within time limit [2019/43]
Fees paidRenewal fee
06.07.2015Renewal fee patent year 03
08.07.2016Renewal fee patent year 04
10.07.2017Renewal fee patent year 05
11.07.2018Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.07.2013
AL14.11.2018
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
MK14.11.2018
MT14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
LU10.07.2019
BE31.07.2019
[2022/31]
Former [2021/34]HU10.07.2013
AL14.11.2018
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
MT14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
LU10.07.2019
BE31.07.2019
Former [2021/33]HU10.07.2013
AL14.11.2018
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
LU10.07.2019
BE31.07.2019
Former [2021/26]AL14.11.2018
AT14.11.2018
CY14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
LU10.07.2019
BE31.07.2019
Former [2021/22]AL14.11.2018
AT14.11.2018
CZ14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
LU10.07.2019
BE31.07.2019
Former [2020/26]AL14.11.2018
AT14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
LU10.07.2019
BE31.07.2019
Former [2020/17]AL14.11.2018
AT14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
TR14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2020/14]AL14.11.2018
AT14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
MC14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/50]AL14.11.2018
AT14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SI14.11.2018
SK14.11.2018
SM14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/40]AL14.11.2018
AT14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SK14.11.2018
SM14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/37]AL14.11.2018
AT14.11.2018
DK14.11.2018
EE14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
PL14.11.2018
RO14.11.2018
RS14.11.2018
SE14.11.2018
SM14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/35]AL14.11.2018
AT14.11.2018
DK14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
PL14.11.2018
RS14.11.2018
SE14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/34]AL14.11.2018
AT14.11.2018
DK14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
IT14.11.2018
LT14.11.2018
LV14.11.2018
RS14.11.2018
SE14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/26]AL14.11.2018
AT14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
LT14.11.2018
LV14.11.2018
RS14.11.2018
SE14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
PT14.03.2019
Former [2019/25]AT14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
LT14.11.2018
LV14.11.2018
RS14.11.2018
SE14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
Former [2019/24]AT14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
LT14.11.2018
LV14.11.2018
SE14.11.2018
BG14.02.2019
NO14.02.2019
GR15.02.2019
IS14.03.2019
Former [2019/23]AT14.11.2018
ES14.11.2018
FI14.11.2018
HR14.11.2018
LT14.11.2018
LV14.11.2018
BG14.02.2019
NO14.02.2019
IS14.03.2019
Former [2019/22]FI14.11.2018
LT14.11.2018
BG14.02.2019
NO14.02.2019
IS14.03.2019
Former [2019/21]FI14.11.2018
LT14.11.2018
NO14.02.2019
IS14.03.2019
Former [2019/20]LT14.11.2018
NO14.02.2019
Cited inInternational search[XI]WO2006136162  (STATENS SERUMINSTITUT [DK], et al) [X] 1-3,13,47 * page 25, line 24 - line 25 * * page 4, line 1 - line 4 * [I] 4-12,21-44;
 [XI]WO2009070700  (AERAS GLOBAL TB VACCINE FOUND [US], et al) [X] 1-13,47 * page 22, line 6 - line 12 * * page 26, line 27 - line 28 * [I] 21-44;
 [XI]WO2011144951  (HEALTH PROT AGENCY [GB], et al) [X] 1-4,13,47 * page 48, line 16 - page 50, line 19 * [I] 5-12,21-44;
 [XI]WO2012057904  (INFECTIOUS DISEASE RES INST [US], et al) [X] 1,2,13,47 * page 42, line 4 - line 31 * * page 29, line 10 - line 31 * [I] 3-12,21-44;
 [AD]  - BALDWIN S L ET AL, "Intradermal immunization improves protective efficacy of a novel TB vaccine candidate", VACCINE, ELSEVIER LTD, GB, vol. 27, no. 23, doi:10.1016/J.VACCINE.2009.03.018, ISSN 0264-410X, (20090518), pages 3063 - 3071, (20090326), XP026058724 [AD] 1-13,21-44,47

DOI:   http://dx.doi.org/10.1016/j.vaccine.2009.03.018
 [A]  - HOUGHTON RAYMOND L ET AL, "Use of multiepitope polyproteins in serodiagnosis of active tuberculosis", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20020701), vol. 9, no. 4, doi:10.1128/CDLI.9.4.883-891.2002, ISSN 1071-412X, pages 883 - 891, XP002511611 [A] 1-13,21-44,47

DOI:   http://dx.doi.org/10.1128/CDLI.9.4.883-891.2002
 [A]  - ANDERSEN ET AL, "Vaccine strategies against latent tuberculosis infection", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, (20070117), vol. 15, no. 1, doi:10.1016/J.TIM.2006.11.008, ISSN 0966-842X, pages 7 - 13, XP005823946 [A] 1-13,21-44,47

DOI:   http://dx.doi.org/10.1016/j.tim.2006.11.008
 [A]  - CHEN LEI ET AL, "The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, (201006), vol. 59, no. 1, ISSN 0928-8244, pages 42 - 52, XP002713096 [A] 1-13,21-44,47

DOI:   http://dx.doi.org/10.1111/j.1574-695X.2010.00660.x
by applicantUS5168062
 WO9428152
 US5494807
 WO9700326
 WO9702355
 WO9802522
 WO9856415
 WO9903885
 US5972597
 WO0050573
 US6133028
 US6136594
 WO0070071
 WO0242480
 US6440422
 WO03000721
 WO03004520
 WO03008533
 WO03035681
 WO03053463
 WO03076601
 WO2004006952
 WO2004083418
 WO2004097016
 WO2005071093
 US6998252
 WO2006053871
 WO2006072787
 WO2006104389
 WO2007147529
 WO2008124647
 WO2008138649
 WO2009004016
 WO2010130756
 WO2010130753
 WO2010135495
 US2011008872
 WO2011144951
 WO2012001075
    - COLE ET AL., NATURE, (1998), vol. 393, pages 537 - 44
    - EHLERS ET AL., INFECTION, (2009), vol. 37, pages 87 - 95
    - ROOK ET AL., J INFECT DIS, (2007), vol. 196, pages 191 - 8
    - COOPER ET AL., ANNU REV IMMUNOL, (2009), vol. 27, pages 393 - 422
    - OTTENHOFF; KAUFMANN, PLOS, (2012), vol. 8, no. 5, page E1002607
    - GRODE ET AL., J CLIN INVEST, (2005), vol. 115, pages 2472 - 9
    - THAISSA ET AL., YALE J. OF BIOL. AND MEDICINE, (2010), vol. 83, pages 209 - 15
    - ANDERSEN, NATURE, (2007), vol. 5, page 484
    - KAUFMAN, TREND IN IMMUNOLOGY, (2012), vol. 241, pages 1 - 7
    - LANGERMANS ET AL., VACCINE, (2005), vol. 23, pages 2740 - 50
    - DIETRICH ET AL., J. IMMUNOL., (2007), vol. 178, pages 3721 - 30
    - VAN DISSEL ET AL., VACCINE, (2010), vol. 28, pages 3571 - 81
    - VAN DISSEL, VACCINE, (2011), vol. 29, pages 2100 - 9
    - AAGAARD ET AL., PLOS ONE, vol. 4, pages 1 - 8
    - VON ESCHEN ET AL., HUM VACCINE, (2009), vol. 5, pages 475 - 82
    - BALDWIN ET AL., VACCINE, (2009), vol. 27, pages 3063 - 71
    - BERTHOLET ET AL., SCI TRANSL MED, (2010), vol. 2, no. 53, page 53RA74
    - MC SHANE ET AL., NAT MED, (2004), vol. 10, pages 1240 - 4
    - SCRIBA ET AL., EUR J IMMUNOL, (2010), vol. 40, pages 279 - 90
    - RADOSEVIC ET AL., INFECT IMMUNOL, (2007), vol. 75, pages 4105 - 15
    - MAGALHAES ET AL., PLOS ONE, (2008), vol. 3, page E3790
    - ABEL ET AL., AM J RESPIR CRIT CARE MED, (2010), vol. 181, pages 1407 - 17
    - DELOGU ET AL., J INFECT DEVELOPING COUNTRIES, (2009), vol. 3, pages 5 - 15
    - AAGAARD ET AL., NATURE MED, (2011), vol. 17, pages 189 - 94
    - LIN ET AL., J CLIN INVEST, (2012), vol. 122, pages 303 - 14
    - GOONETILLEKE ET AL., J. IMMUNOL., (2003), vol. 171, pages 1602 - 9
    - DAYHOFFED, Atlas of Protein Sequence and Structure, (1981), vol. 3, pages 482 - 9
    - COLE ET AL., NATURE, (1998), vol. 393, page 537
    - BERTHOLET ET AL., J. IMMUNOL., (2008), vol. 181, pages 7948 - 57
    - BERTHOLET, SCI TRANSL MED, (2010), vol. 2, page 53RA74
    - VOSKUIL ET AL., J. EXP MED, (2003), vol. 198, pages 705 - 13
    - LEYTEN ET AL., MICROBES INF., (2006), vol. 8, pages 2052 - 60
    - ROUPIE ET AL., INFECTION AND IMMUNITY, (2007), vol. 75, pages 941 - 9
    - BLACK ET AL., CLIN VACCINE IMMUNOL, (2009), vol. 16, pages 1203 - 12
    - SCHUCK ET AL., PLOS ONE, (2009), vol. 4, page E5590
    - VIPOND ET AL., VACCINE, (2006), vol. 24, pages 6340 - 50
    - VIPOND ET AL., TUBERCULOSIS, (2007), vol. 86, pages 218 - 24
    - BERTHOLET ET AL., SCI TRANSL MED, (2010), vol. 2, page 53RA74
    - MOLLENKOPF ET AL., INFECT IMMUN, (2004), vol. 72, pages 6471 - 9
    - MUKAMOLOVA ET AL., MOL MICROBIOL, (2002), vol. 46, pages 623 - 35
    - YEREMEEV ET AL., INFECTION AND IMMUNITY, (2003), vol. 71, pages 4789 - 94
    - MUKAMOLOVA ET AL., MOL MICROBIOL, (2006), vol. 59, pages 84 - 98
    - TUFARIELLO ET AL., INFECT IMMUN, (2006), vol. 74, pages 2985 - 95
    - BIKETOV ET AL., MMC INFECT DIS, (2007), vol. 7, page 146
    - KANA ET AL., MOL MICROBIOL, (2008), vol. 67, pages 672 - 84
    - KANA ET AL., FEMS IMMUNOL MED MICROBIOL, (2009), vol. 58, pages 39 - 50
    - RUSSEL-GOLDMAN ET AL., INFECT IMMUN, (2008), vol. 76, pages 4269 - 81
    - GUPTA ET AL., MICROBIOL, (2010), vol. 156, pages 2714 - 22
    - COMMANDEUR ET AL., CLIN VACCINE IMMUNOL., (2011), vol. 18, pages 676 - 83
    - CABRERA ET AL., ARCH BIOCHEM BIOPHYS, (2010), vol. 502, pages 23 - 30
    - CHENG ET AL., J. CLIN. INVEST., (2001), vol. 108, page 669
    - CHEN ET AL., CANCER RES., (2000), vol. 60, page 1035
    - RODRIGUEZ ET AL., J. VIROL., (1997), vol. 71, page 8497
    - SIDNEY ET AL., IMMUNITY, (1994), vol. 1, page 751
    - VORDERMEIER ET AL., EUR. J. IMMUNOL., (1992), vol. 22, page 2631
    - PANINA-BORDIGNON ET AL., EUR. J. IMMUNOL., (1989), vol. 19, page 2237
    - DEMOTZ ET AL., EUR. J. IMMUNOL., (1993), vol. 23, page 425
    - ROTHBARD ET AL., INT. IMMUNOL., (1989), vol. 1, page 479
    - SPENCER ET AL., PLOS ONE, (2012), vol. 7, page E33555
    - LUSKY ET AL., J. VIROL, (1998), vol. 72, page 2022
    - ANTOINE ET AL., VIROL., (1998), vol. 244, page 365
    - BRANDLER ET AL., CIMID, (2008), vol. 31, page 271
    - SINGH ET AL., J. VIROL., (1999), vol. 73, no. 6, page 4823
    - GRIFFIN ET AL., FIELD'S IN VIROLOGY, (2001), pages 1401 - 1441
    - SCHWARZ A, AM J DIS CHILD, (1962), vol. 103, page 216
    - ZHANG ET AL., J MED VIROL., (2009), vol. 81, no. 8, page 1477
    - ERBS ET AL., CANCER GENE THER., (2008), vol. 15, page 18
    - CHAKRABARTI ET AL., BIOTECHNIQUES, (1997), vol. 23, pages 1094 - 7
    - HAMMOND ET AL., J. VIROL METHODS, (1997), vol. 66, pages 135 - 8
    - KUMAR; BOYLE, VIROLOGY, (1990), vol. 179, pages 151 - 8
    - BRANDLER; TANGY, CIMID, (2008), vol. 31, page 271
    - GRAHAM ET AL., J. GEN. VIROL., (1997), vol. 36, pages 59 - 72
    - FALLAUX ET AL., HUMAN GENE THER., (1998), vol. 9, pages 1909 - 17
    - A. GENNARO, Remington : The Science and Practice of Pharmacy, LIPPINCOTT, WILLIAMS&WILKINS
    - RIBI ET AL., Immunology and Immunopharmacology of Bacterial Endotoxins, PLENUM PUBL. CORP., (1986), pages 407 - 419
    - KRITSCH ET AL., J. CHROMATOGR ANAL. TECHNOL BIOMED LIFE SCI, (2005), vol. 822, page 263
    - RIANO ET AL., TUBERCULOSIS, (2012), vol. 92, pages 148 - 59
    - ASHWIN ET AL., AM J RESP, (2008), vol. 39, pages 503 - 8
    - ACOSTA ET AL., MALAYS J MED, (2011), vol. 18, pages 5 - 12
    - HOUGARDY ET AL., PLOS ONE, (2007), vol. 2, no. 10, page E926
    - RUHWALD ET AL., MICROBES INFECT, (2008), vol. 9, pages 806 - 12
    - BRAUN ET AL., GENE THER., (2000), vol. 7, page 1447
    - FALKNER ET AL., J. VIROL., (1988), vol. 62, pages 1849 - 54
    - STUDIER, "AI medium containing glucose/lactose and antibiotic", PROTEIN EXPR PURIF., (2005), vol. 41, pages 207 - 34
    - HIMOUDI ET AL., J. VIROL., (2002), vol. 76, pages 12735 - 46
    - HARTINGS ET AL., J PHARMACOL TOXICOL METHODS, (2004), vol. 49, pages 39 - 55
    - JAMES ET AL., J APPL MICROBIOL, (2000), vol. 88, pages 669 - 77
    - AAGAARD ET AL., NAT MED, (2011), vol. 17, pages 189 - 194
    - YEREMEEV ET AL., INFECT IMMUN, (2003), vol. 71, pages 4789 - 94
    - KOLILAB ET AL., CLIN VACCINE IMMUNOL, (2010), vol. 17, pages 793 - 801
    - MALIN ET AL., MICROBES INFECT, (2000), vol. 2, pages 1677 - 85
    - MU ET AL., MOL THER, (2009), vol. 17, pages 1093 - 100
    - DIETRICH ET AL., J IMMUNOL, (2005), vol. 174, pages 6332 - 9
    - HAVENGA ET AL., J GEN VIROL, (2006), vol. 87, pages 2135 - 43
    - SHARPE ET AL., J MOL BIOL, (2008), vol. 383, pages 822 - 36
    - BUCHKO ET AL., BACTERIOL, (2006), vol. 188, pages 5993 - 6001
    - RUGGIERO ET AL., J MOL BIOL, (2009), vol. 385, pages 153 - 62
    - COHEN-GONSAUD ET AL., NAT STRUCT MOL BIOL, (2005), vol. 12, pages 270 - 3
    - STRONG ET AL., PROC NATL ACAD SCI, (2006), vol. 103, pages 8060 - 5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.